Finance

Lists
Why is 31R up 40.00%?
Dive Deeper
31R:FRA
Revive Therapeutics Ltd
€0.010
+40.00%
(+0.0030) 1D
Sep 29, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 31R...
Open
€0.00
High
€0.01
Low
€0.00
Mkt. cap
12.58M
Avg. vol.
2.77K
Volume
0.00
52-wk high
€0.06
52-wk low
€0.00
Open
€0.00
High
€0.01
Low
€0.00
Mkt. cap
12.58M
Avg. vol.
2.77K
Volume
0.00
52-wk high
€0.06
52-wk low
€0.00
About Revive Therapeutics Ltd
CEO-
Employees-
Founded2012
HeadquartersToronto, Ontario, Canada
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
336.32K
200.14K
283.25K
242.05K
Operating expense
336.39K
220.13K
283.30K
463.87K
Total operating expenses
336.39K
220.13K
283.30K
463.87K
Operating income
-336.39K
-220.13K
-283.30K
-463.87K
Other non operating income
73.85K
-
-
-
EBT including unusual items
-9.60M
-281.75K
-238.72K
-506.50K
EBT excluding unusual items
-143.94K
-281.75K
-234.70K
-506.50K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.60M
-281.75K
-238.72K
-506.50K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
277.00
-
-
Interest expense
-
-
-
-
Net interest expenses
-
277.00
-
-
Depreciation and amortization charges
62.00
46.00
48.00
47.00
EBITDA
-336.32K
-220.08K
-283.25K
-463.82K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps